Latest FENC News

• Analyst Ratings for Fennec Pharmaceuticals - Benzinga - Thu, Apr 6, 2023 1:00 PM
• Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients - GlobeNewswire Inc. - Fri, Mar 31, 2023 12:03 PM
• Adherex Technologies Inc. (FENC) Reports Q4 Loss, Lags Revenue Estimates - Zacks Investment Research - Thu, Mar 30, 2023 11:15 AM
• Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results - GlobeNewswire Inc. - Thu, Mar 30, 2023 9:55 AM
• Why Earnings Season Could Be Great for Adherex Technologies (FENC) - Zacks Investment Research - Thu, Feb 23, 2023 1:44 PM
• Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA - GlobeNewswire Inc. - Tue, Jan 31, 2023 11:00 AM
• Fennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PEDMARK® (sodium thiosulfate injection) to Reduce the Risk of Cisplatin-Induced Hearing Loss in Pediatric Patients - GlobeNewswire Inc. - Wed, Jan 25, 2023 12:19 PM
• Expert Ratings for Fennec Pharmaceuticals - Benzinga - Tue, Nov 22, 2022 8:05 PM
• What 4 Analyst Ratings Have To Say About Fennec Pharmaceuticals - Benzinga - Tue, Nov 22, 2022 7:01 PM
• 4 Analysts Have This to Say About Fennec Pharmaceuticals - Benzinga - Tue, Nov 22, 2022 5:02 PM